Literature DB >> 26800406

Planning and Implementation of Low-Dose Computed Tomography Lung Cancer Screening Programs in the United States.

Rebecca Qiu1, Amy Copeland2, Erica Sercy3, Nancy R Porter3, Karen Kane McDonnell4, Jan Eberth3.   

Abstract

BACKGROUND: One of the largest, most expensive randomized, controlled trials, the National Lung Screening Trial, found that annual low-dose computed tomography (LDCT) scans led to a 20% reduction in lung cancer deaths.
OBJECTIVES: This study describes the characteristics and program implementation barriers experienced by LDCT screening programs in the United States.
METHODS: Using a mixed-methods approach, Lung Cancer Alliance Screening Centers of Excellence were surveyed and interviewed in 2013. Representatives from 65 centers completed an electronic questionnaire, followed by in-depth interviews with 13 physicians and nurse navigators regarding their institution's screening programs.
FINDINGS: Participants cited low patient demand and few physician referrals as barriers, but few centers reported needing additional staff or equipment. Those interviewed discussed the importance of a multidisciplinary team and overcoming barriers related to insurance reimbursement, costs, and physician knowledge to improve program implementation.

Entities:  

Keywords:  early detection of cancer; health services research; lung neoplasms; spiral computed tomography

Mesh:

Year:  2016        PMID: 26800406     DOI: 10.1188/16.CJON.52-58

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  6 in total

1.  Lung Cancer Screening Practices in North Carolina CT Facilities.

Authors:  Louise M Henderson; Laura M Jones; Mary W Marsh; Thad Benefield; M Patricia Rivera; Paul L Molina
Journal:  J Am Coll Radiol       Date:  2016-10-27       Impact factor: 5.532

2.  The Effect of Primary Care Physician Knowledge of Lung Cancer Screening Guidelines on Perceptions and Utilization of Low-Dose Computed Tomography.

Authors:  Dan J Raz; Geena X Wu; Martin Consunji; Rebecca A Nelson; Heeyoung Kim; Can-Lan Sun; Virginia Sun; Jae Y Kim
Journal:  Clin Lung Cancer       Date:  2017-06-01       Impact factor: 4.785

3.  Using the New CellCollector to Capture Circulating Tumor Cells from Blood in Different Groups of Pulmonary Disease: A Cohort Study.

Authors:  Yutong He; Jin Shi; Gaofeng Shi; Xiaoli Xu; Qingyi Liu; Congmin Liu; Zhaoyu Gao; Jiaoteng Bai; Baoen Shan
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

4.  Geographical Variation and Factors Associated with Non-Small Cell Lung Cancer in Manitoba.

Authors:  David E Dawe; Harminder Singh; Lahiru Wickramasinghe; Marshall W Pitz; Mahmoud Torabi
Journal:  Can Respir J       Date:  2017-06-21       Impact factor: 2.409

5.  Engaging veteran stakeholders to identify patient-centred research priorities for optimizing implementation of lung cancer screening.

Authors:  Alice Yan; Katinka Hooyer; Onur Asan; Mark Flower; Jeff Whittle
Journal:  Health Expect       Date:  2021-12-10       Impact factor: 3.377

6.  Rural areas are disproportionately impacted by smoking and lung cancer.

Authors:  Wiley D Jenkins; Alicia K Matthews; Angie Bailey; Whitney E Zahnd; Karriem S Watson; Georgia Mueller-Luckey; Yamile Molina; David Crumly; Julie Patera
Journal:  Prev Med Rep       Date:  2018-03-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.